TRCT
MMED

Tower Research Capital (TRC)’s MiniMed Group Inc MMED Stock Holding History

Tower Research Capital (TRC)’s Portfolio MMED Stock Details MMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33K Buy
+2,205
New +$29.1K ﹤0.01% 3095

Other funds holding MMED

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $4.58B AUM 43.91% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Tower Research Capital (TRC)'s MMED Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in MiniMed Group Inc (MMED) in Q2 2026: 2,205 shares worth $33K. The stake represents ﹤0.01% of the portfolio and ranks #3095 among its holdings.

98 funds tracked by Wall St. Rank hold MMED as of Q2 2026.

  • Tower Research Capital (TRC) held 2,205 shares of MiniMed Group Inc worth $33K as of Q2 2026.
  • MiniMed Group Inc was a new Tower Research Capital (TRC) position in Q2 2026.
  • MiniMed Group Inc made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3095 holding.
  • 98 funds tracked by Wall St. Rank held MiniMed Group Inc as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.